Currently out of the existing stock ratings of Dave Weiner, 30 are a BUY (83.33%), 6 are a HOLD (16.67%).

Dave Weiner

Work Performance Price Targets & Ratings Chart

Analyst Dave Weiner, carries an average stock price target met ratio of 63.33% that have a potential upside of 21.69% achieved within 817 days. Previously, Dave Weiner worked at DEUTSCHE BANK.

Dave Weiner’s has documented 93 price targets and ratings displayed on 7 stocks. The coverage was on Consumer Cyclical, Healthcare sectors.

Most recent stock forecast was given on MYGN, Myriad Genetics at 14-May-2025.

Wall Street Analyst Dave Weiner

Analyst best performing recommendations are on LULU (LULULEMON ATHLETICA).
The best stock recommendation documented was for LULU (LULULEMON ATHLETICA) at 12/6/2016. The price target of $62 was fulfilled within 2 days with a profit of $4.76 (8.32%) receiving and performance score of 41.58.

Average potential price target upside

LULU Lululemon Athletica NKE Nike RL Ralph Lauren Corp VFC VF UA Under Armour C CPRI Capri Holdings Ltd MYGN Myriad Genetics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$303

$135.49 (80.88%)

$303

9 days ago
(07-Oct-2025)

1/4 (25%)

$128.18 (73.32%)

134

Hold

$192

$24.49 (14.62%)

$192

22 days ago
(24-Sep-2025)

6/13 (46.15%)

$19.99 (11.62%)

181

Hold

$195

$27.49 (16.41%)

$225

24 days ago
(22-Sep-2025)

43/54 (79.63%)

$21.67 (12.50%)

234

Hold

$185

$17.49 (10.44%)

$210

1 months 5 days ago
(11-Sep-2025)

6/16 (37.5%)

$25.13 (15.72%)

337

Buy

$220

$52.49 (31.34%)

1 months 12 days ago
(04-Sep-2025)

7/8 (87.5%)

$52.2 (31.11%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Dave Weiner is most bullish on?

Potential upside of $1.5 has been obtained for MYGN (MYRIAD GENETICS)

What Year was the first public recommendation made by Dave Weiner?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?